Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
NCT00968240
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Anaplastic Astrocytoma
Interventions
DRUG:
Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB
Sponsor
Northwell Health